Showing results (261-270 of 604) with videos related to

Sort By:
Pageof 61
Joint Bone Spine|June 30, 2009
Abatacept therapy and safety managementThao Pham, Pascal Claudepierre, Arnaud Constantin, et al.
RMD Open|March 20, 2019
Undifferentiated connective tissue disease: state of the art on clinical practice guidelinesMargarida Antunes, Carlo Alberto Scirè, Rosaria Talarico, et al.
Rheumatology (Oxford, England)|March 19, 2011
Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up studyJulien Wipff, Romain Coriat, Michela Masciocchi, et al.
Autoimmunity Reviews|September 16, 2014
Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter studyAntoine Néel, Benoit Henry, Sebastien Barbarot, et al.
RMD Open|November 8, 2018
Antiphospholipid syndrome: state of the art on clinical practice guidelinesMarteen Limper, Carlo Alberto Scirè, Rosaria Talarico, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 4, 2015
Factors associated with hospital admission in hereditary angioedema attacks: a multicenter prospective studyNicolas Javaud, Anne Gompel, Laurence Bouillet, et al.
The Journal of Rheumatology|December 25, 2009
Association between a CTGF gene polymorphism and systemic sclerosis in a French populationBrigitte Granel, Laurent Argiro, Eric Hachulla, et al.
Annals of the Rheumatic Diseases|August 29, 2014
Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective studyJérôme Avouac, Ulrich A Walker, Eric Hachulla, et al.
Clinical and Experimental Rheumatology|March 29, 2022
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centresLiala Moschetti, Luisa Dal Pozzolo, Veronique Le Guern, et al.
Plos One|November 6, 2015
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II TrialYves Allenbach, Marguerite Guiguet, Aude Rigolet, et al.
Pageof 61